ARV-393 is an orally active PROTAC degrader targeting BCL6 for studies related to diffuse large B-cell lymphoma. ARV-393 utilizes the ubiquitin-proteasome system to target the degradation of BCL6.
Molecular Weight:
898.42
Purity:
>99.0%
CAS Number:
[2851885-95-3]
Formula:
C46H53ClFN9O7
Target:
PROTAC
* VAT and and shipping costs not included. Errors and price changes excepted